Author:
Saarikoski Tuukka,Saari Teijo I.,Hagelberg Nora M.,Neuvonen Mikko,Neuvonen Pertti J.,Scheinin Mika,Olkkola Klaus T.,Laine Kari
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference43 articles.
1. Finnish Medicines Agency (FIMEA) (2010) Finnish Statistics on Medicines. Available at: http://raportit.nam.fi/raportit/kulutus/ev_laakekulutus.pdf . Accessed 7 Mar 2012
2. Lintz W, Barth H, Osterloh G, Schmidt-Bothelt E (1986) Bioavailability of enteral tramadol formulations. 1st communication: capsules. Arzneimittelforschung 36(8):1278–1283
3. Gillen C, Haurand M, Kobelt DJ, Wnendt S (2000) Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn Schmiedebergs Arch Pharmacol 362(2):116–121
4. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL (1992) Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic. J Pharmacol Exp Ther 260(1):275–285
5. Wu WN, McKown LA, Liao S (2002) Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites. Xenobiotica 32(5):411–425. doi: 10.1080/00498250110113230
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献